Premier Account Manager
About the job
- Advanced account management expertise integrating artificial intelligence-driven analytics, customer relationship management systems, and data visualization tools to optimize decision-making, performance tracking, and strategic account planning in complex, high-growth environments.
- Strong clinical and commercial acumen, with the ability to synthesize therapeutic knowledge, provider workflows, and market dynamics into actionable strategies that drive measurable business outcomes.
- Exceptional communication and relationship-building skills to influence senior healthcare stakeholders while using artificial intelligence tools to enhance personalization, responsiveness, and engagement quality.
- High learning agility and the ability to adapt quickly in regulated environments, applying emerging technologies and insights to improve execution, compliance, and customer impact.
- Four to six years of experience in pharmaceutical sales, specialty pharmacy account management, or a comparable customer-facing healthcare role, with demonstrated ownership of high-value accounts.
- A proven track record of driving revenue retention, expansion, and relationship recovery within complex, high-stakes account portfolios.
- Demonstrated clinical fluency to independently and credibly engage physicians, pharmacists, and healthcare operators on therapeutic and compliance-related topics.
- Experience conducting Executive Business Reviews, managing performance metrics, and maintaining disciplined customer relationship management documentation standards.
- Proficiency with Salesforce or equivalent customer relationship management platforms, with a strong emphasis on data integrity and workflow optimization.
- A bachelor's degree in Business, Healthcare Administration, Life Sciences, Marketing, or a related field is preferred.
- Ability to meet the stated physical requirements, including remaining stationary for significant portions of the workday, using hands and fingers to operate computer and office productivity devices, moving around the office and corporate campus, and standing, walking, reaching, climbing or balancing, and stooping, kneeling, crouching, or crawling.
- Develop and execute strategic account plans to drive growth and revenue across the portfolio; use artificial intelligence-driven insights to identify opportunities and tailor solutions to client needs, and achieve growth targets through understanding market dynamics.
- Cultivate long-lasting relationships with key stakeholders across client organizations; use artificial intelligence tools to personalize interactions, anticipate needs, and deliver high client satisfaction and engagement.
- Conduct market analysis using artificial intelligence analytics to identify emerging trends and competitive threats, and provide strategic recommendations that enhance market positioning and the client value proposition.
- Implement and refine account management processes to improve efficiency and effectiveness; use artificial intelligence to streamline operations, reduce manual tasks, maintain quality control, and improve service delivery and client satisfaction.
- Use artificial intelligence-powered data analytics to inform decisions and strategic planning; analyze performance metrics and key performance indicators to optimize account management strategies and operational performance and client outcomes.
- Ensure client interactions and processes comply with industry regulations and company policies; use artificial intelligence to maintain compliance in the 503A/503B environment and safeguard company reputation and client trust.
- Lead and mentor a high-performing account management team, foster continuous learning and innovation, and use artificial intelligence tools for skill enhancement and professional development.
- Drive cross-functional collaboration to align product development, marketing, and sales efforts with account goals; use artificial intelligence to facilitate communication and coordination and deliver integrated solutions that meet client expectations.
- Oversee team performance metrics and implement artificial intelligence-enhanced feedback systems; set clear goals and provide real-time performance insights to support team accountability and motivation.
- Build trust through customer-centric solutions.
- Guide responsible artificial intelligence adoption and adaptation.
- Drive efficiency through continuous improvement and optimized work processes.
- Partner effectively to achieve shared goals.
- Secure and deploy resources efficiently.
- Simplify and solve complex challenges.
- Deliver on commitments with integrity and accountability.
- Adjust approaches to shifting conditions.
- Tailor messages to diverse audiences.
About the company
Empower Pharmacy and Empower Pharma provide personalized, high-quality compounded medications at scale. They customize dosages, remove allergens, and create multi-drug combinations that aren’t available through standard options. Operating with a vertically integrated model as licensed manufacturer, wholesaler, and pharmacy, they streamline the pharmaceutical supply chain to reduce costs without compromising quality. The company serves both healthcare providers (B2B) and individual patients (B2C), manufacturing over 400 medications for millions across all 50 states and internationally. Based in Houston, Texas, Empower runs a 503A compounding pharmacy and a 503B outsourcing facility, focusing on patient safety, excellent service, and advanced technology to expand access to affordable, effective healthcare.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Houston, Texas
Founded
2009
Get referred to Empower Pharmacy
See people who can refer or advise you
Simplify's Take
What believers are saying
- Demand for compounded GLP-1 alternatives remains strong despite Novo Nordisk and Eli Lilly shortages ending.
- Empower announced a March 11, 2026 FDA-registered 503B facility, expanding regulated manufacturing capacity.
- LO3 Capital's 2023 investment and Aurobindo asset acquisition support capital access and infrastructure expansion.
What critics are saying
- FDA's September 18, 2026 warning letter cites illegal copycat GLP-1 compounding and sterility failures.
- This is Empower's fifth warning letter since 2017, signaling persistent compliance weaknesses.
- An injunction or seizure after missed remediation would cripple GLP-1 revenue and trigger existential scrutiny.
What makes Empower Pharmacy unique
- Empower runs 503A and 503B facilities, serving clinics with nationwide overnight shipping.
- Empower sells GLP-1 blends like semaglutide-cyanocobalamin and tirzepatide-niacinamide across patient-specific formats.
- Empower has FDA-registered outsourcing capacity and PCAB accreditation, supporting large-scale compounding operations.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
401(k) Company Match
Wellness Program
Growth & Insights and Company News
6 month growth
28%1 year growth
28%2 year growth
28%FDA warns Pharmacy about illegal GLP-1 compounding. - Agency's letter flagged issues with copycat manufacturing and sterility by Kristen Monaco, Senior Staff Writer, MedPage Today The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded GLP-1 weight-loss and diabetes drugs, citing illegal copycat manufacturing and insanitary conditions. Following a facility inspection in November 2025, the agency determined that Empower produced large quantities of drugs that were "essentially copies of FDA-approved semaglutide [Ozempic, Wegovy] and tirzepatide [Mounjaro, Zepbound] products," in violation of Section 503A of the Federal Food, Drug, and Cosmetic Act. "The volume of products you are producing suggests that differences between products you are compounding and the FDA-approved products are pretextual," the FDA wrote in the letter, dated Sept. 18. Under Section 503A, licensed compounding pharmacies are permitted to tailor customized medications for individual patient needs. However, they are prohibited from regularly compounding "in inordinate amounts" any drugs that copy commercially available products without a documented, individualized clinical rationale from a prescriber. Compounded formulations cited in the letter combined active GLP-1 ingredients with added B vitamins - specifically tirzepatide mixed with niacinamide, and semaglutide mixed with cyanocobalamin. Because Empower failed to meet Section 503A conditions, its products lost statutory exemptions and were reclassified as unapproved new drugs and misbranded products. Additionally, FDA inspectors found that sterile drug products were prepared, packed, or held under insanitary conditions and thereby could be "contaminated with filth or rendered injurious to health." Other key violations included: * Failure to perform smoke studies under dynamic conditions to confirm proper airflow in ISO 5 clean room areas * Performing media fills under non-stressful conditions, therefore not guaranteeing aseptic technique * Inadequate environmental monitoring, equipment maintenance, and quality control unit oversight Some of Empower's subsequent corrective actions were adequate while others were deficient, the FDA noted. The compounder has 15 working days to respond. The warning letter follows intensified efforts to crack down on GLP-1 compounding this year. The surge in GLP-1 compounding began a few years ago when high demand triggered widespread shortages. However, shortages of tirzepatide (resolved in December 2024) and semaglutide (resolved in February 2025) have since ended.
Eli Lilly sues Empower Pharmacy over tirzepatide - what medspas need to know ASAP.
HOUSTON, June 21, 2024 /PRNewswire/ -- Empower Pharmacy is pleased to announce its selection as a finalist in the prestigious Best Family-Owned Business Awards, organized by the Houston Business Journal (HBJ). This recognition underscores Empower Pharmacy's commitment to excellence, innovation, and community investment within the Houston business landscape.The Best Family-Owned Business Awards, presented by HBJ, spotlight companies that not only demonstrate financial success but also exhibit a significant commitment to their community investment. Empower Pharmacy was handpicked by HBJ staff and nominated by esteemed members of the Houston business community for its significant impact as an employer and longstanding presence in the region.Empower Pharmacy has been categorized within the large company list, demonstrating its substantial presence and impact as a large employer within the Houston area. To qualify for consideration, all nominees had to meet stringent criteria set by HBJ, including being at least 51% owned by the family, involving multiple generations in company operations, and exhibiting longevity in business."We are honored to be recognized as a finalist in the Best Family-Owned Business Awards," said Shaun Noorian, CEO of Empower Pharmacy. "This acknowledgment reflects our dedication to family values and our deep-rooted commitment to serving our community as we grow. Today, Empower has over 1,000 employees with over 90% located in Houston, and remains a family centered thanks to the hard work and dedication of our entire team."Empower continues to uphold its commitment to providing personalized healthcare solutions of compounded medicines to providers and patients in the Houston area and beyond
Amidst a period of significant expansion, Empower Pharmacy embarks on a strategic rebranding initiative, aimed at enhancing customer and employee experience and reinforcing its commitment to excellenceHOUSTON, May 1, 2024 /PRNewswire/ -- Empower Pharmacy, the country's most advanced compounding pharmacy, today announced a significant milestone with the launch of its brand refresh, signaling the start of a new chapter aimed at enhancing healthcare accessibility and elevating patient, provider, and employee experiences. This comprehensive update reflects the company's commitment to excellence, innovation, and customer-centricity represented by a vibrant brand, redesigned website, and new employee talent program.The brand refresh marks a new era for Empower, highlighting its dedication to enhancing services for customers and employees alike. By actively seeking feedback from both groups, Empower ensures that customers' and employees' needs are met, and experiences continually improved, underscoring the company's ongoing dedication to excellence through responsiveness and improvement."We are launching this fresh approach to meet the needs of our consumers – both patients and providers – on their wellness journey through quality and affordable customized medication," said Shaun Noorian, CEO of Empower. "Our growth throughout the last decade has mirrored the transformation of pharmacy from big box retail brick-and-mortar to consumer-driven health and wellness telehealth." Telehealth is serving consumers nationwide with reportedly more than 35% of individuals aged 18 and over relying on telemedicine in the past year.Empower's Chief Sales and Marketing Officer, Nicole R. Braley, highlighted that "recent surveys indicate that 71% of respondents have turned to online pharmacies in the last one to three years, highlighting the demand for better digital services.1 As part of our strategic rebranding, we are striving to ensure the greater market fully understands the opportunities available through a compounding pharmacy. By exceeding expectations in how we meet their needs, we set a new standard for the industry."Key elements of the brand refresh include a new visual identity that showcases Empower's commitment to excellence and innovation
In February, drug compounder Empower Pharmacy announced that it planned to buy the 170,000-square-foot Eugia facility for an undisclosed price and retain its workforce.